The proportion of fetuses and infants with Zika virus–associated birth defects is highest among women with first and early second trimester infections (29); therefore, conducting all NAT during the first and second trimesters might be considered to help identify infections early in pregnancy. This evidence concerns the gene BRD2 and infection.